# Xenagos Bio, Inc. — Form D

Xenagos Bio, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-15. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-05-15
- Form: D
- Accession: 0002134608-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-584166

## Issuer

- Name: Xenagos Bio, Inc.
- CIK: 0002134608
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 121 S. BROAD ST., 15TH FLOOR, #1015, PHILADELPHIA, PA, 19107
- Phone: (610) 716-3542

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Abel De La Rosa | Related Person | Philadelphia, PA |
| Patrick Higgins | Related Person | Philadelphia, PA |
| Michael J. McElhaugh | Related Person | Philadelphia, PA |

## More

- [CIK 2134608 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2134608&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002134608-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.